发明名称 Treatment of hepatitis C virus
摘要 A combined therapy which utilizes hydroxychloroquine and GNS-227:; for the treatment of an HCV-related disease, including HCV chronic infection, is disclosed. Further disclosed is pharmaceutical composition (e.g., as a unit dosage form) comprising hydroxychloroquine and GNS-227.
申请公布号 US8912141(B2) 申请公布日期 2014.12.16
申请号 US201214128684 申请日期 2012.06.21
申请人 Panmed Ltd. 发明人 Halfon Philippe
分类号 A61K31/4706;A61K45/06;A61K38/06;A61K31/405 主分类号 A61K31/4706
代理机构 代理人
主权项 1. A method of treating a hepatitis C virus (HCV) infection in a subject in need thereof, the method comprising co-administering to the subject a therapeutically effective amount of hydroxychloroquine or a pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of the compound GNS-227:thereby treating the HCV infection, wherein said therapeutically effective amount of hydroxychloroquine and said therapeutically effective amount of said GNS-227 are selected such that said hydroxychloroquine and said GNS-227 act in synergy in reducing HCV replication.
地址 Beersel BE